The tale of a tail: The secret behind IGF-1R’s oncogenic power-Reference-Cited by-同舟云学术

The tale of a tail: The secret behind IGF-1R’s oncogenic power

Published:2020-05-26 Issue:633 Volume:13 Page:
ISSN:1945-0877
Container-title:Science Signaling
language:en
Short-container-title:Sci. Signal.

Author:

Crudden Caitrin¹²^ORCID,Girnita Leonard¹^ORCID

Affiliation:

1. Department of Oncology and Pathology, BioClinicum, Karolinska Institutet and Karolinska University Hospital, 17164 Stockholm, Sweden.

2. Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.

Abstract

The C-terminal tail of IGF-1R promotes cancer cell migration by mediating adhesion-dependent translocation to the Golgi (Rieger et al ., in 26 May 2020 issue).

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference10 articles.

1. Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation

2. The insulin-like growth factor-I receptor as a target for cancer therapy

3. Distinctive effects of the carboxyl-terminal sequence of the insulin-like growth factor I receptor on its signaling functions

4. Selective recruitment of G protein-coupled receptor kinases (GRKs) controls signaling of the insulin-like growth factor 1 receptor

5. Blurring Boundaries: Receptor Tyrosine Kinases as functional G Protein-Coupled Receptors

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autocrine IGF-II-Associated Cancers: From a Rare Paraneoplastic Event to a Hallmark in Malignancy;Biomedicines;2023-12-22

2. Hallmarks of cancer: The insulin-like growth factors perspective;Frontiers in Oncology;2022-11-21

3. IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma;Oncogene;2021-11-17